These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14440043)

  • 21. Serial changes in coagulant activities after thrombolytic therapy for acute myocardial infarction.
    Goto S; Kawai Y; Abe S; Takahashi E; Handa S; Ogawa S; Watanabe K; Hori S; Ikeda Y
    Angiology; 1994 Apr; 45(4):273-81. PubMed ID: 8161005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [ROLE OF THE FIBRINOLYTIC ACTIVITY IN THE TREATMENT OF CORONARY THROMBOSIS].
    LABOS I
    Med Glas; 1963; 17():251-2. PubMed ID: 14181694
    [No Abstract]   [Full Text] [Related]  

  • 23. Fibrinolytic therapy of coronary thrombosis. Controlled trial of 75 cases.
    DEWAR HA; STEPHENSON P; HORLER AR; CASSELLS-SMITH AJ; ELLIS PA
    Br Med J; 1963 Apr; 1(5335):915-20. PubMed ID: 14027424
    [No Abstract]   [Full Text] [Related]  

  • 24. [Anticoagulant therapy of myocardial infarct and intractable angina pectoris].
    LENEGRE J; BEAUMONT JL
    Presse Med (1893); 1952 Oct; 60(66):1395-7. PubMed ID: 13027035
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
    Collen D; Lijnen HR
    Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [INCIDENCE AND MORPHOLOGY OF CORONARY THROMBOSIS AND THEIR RELATION TO ANTITHROMBOSIS AND FIBRINOLYTIC TREATMENT].
    SINAPIUS D
    Klin Wochenschr; 1965 Jan; 43():37-43. PubMed ID: 14299770
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of cardiac infarct].
    STEINMANN B
    Praxis; 1952 Mar; 41(11):213-8. PubMed ID: 14929827
    [No Abstract]   [Full Text] [Related]  

  • 28. Fibrin specificity and procoagulant effect related to the kallikrein-contact phase system and to plasmin generation with double-bolus reteplase and front-loaded alteplase thrombolysis in acute myocardial infarction.
    Hoffmeister HM; Kastner C; Szabo S; Beyer ME; Helber U; Kazmaier S; Baumbach A; Wendel HP; Heller W
    Am J Cardiol; 2000 Aug; 86(3):263-8. PubMed ID: 10922430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombolytic therapy.
    SHERRY S
    South Med J; 1961 Nov; 54():1287-92. PubMed ID: 13911736
    [No Abstract]   [Full Text] [Related]  

  • 30. Thrombolytic therapy in acute myocardial infarction: comparison of procoagulant effects of streptokinase and alteplase regimens with focus on the kallikrein system and plasmin.
    Hoffmeister HM; Szabo S; Kastner C; Beyer ME; Helber U; Kazmaier S; Wendel HP; Heller W; Seipel L
    Circulation; 1998 Dec; 98(23):2527-33. PubMed ID: 9843458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo fibrinolytic activity and pharmacology of various plasmin (fibrinolysin) preparations.
    BACK N; AMBRUS JL; GOLDSTEIN S; HARRISSON JW
    Circ Res; 1956 Jul; 4(4):440-3. PubMed ID: 13330188
    [No Abstract]   [Full Text] [Related]  

  • 32. Thrombolytic therapy in acute myocardial infarction.
    Andrien P; Lemberg L
    Heart Lung; 1990 Jan; 19(1):102-4. PubMed ID: 2105284
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies of inhibition of the plasmin-plasminogen fibrinolytic enzyme system in patients with myocardial infarction.
    SANDBERG H; TSITOURIS G; DELEON AC; BELLET S
    Am J Cardiol; 1960 May; 5():666-73. PubMed ID: 14441369
    [No Abstract]   [Full Text] [Related]  

  • 34. Modified fibrinolytic technique for analysis of the plasmin system.
    MAXWELL RE; LEWANDOWSKI V
    Anal Biochem; 1962 Nov; 4():407-12. PubMed ID: 13934069
    [No Abstract]   [Full Text] [Related]  

  • 35. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of fibrinolysin and streptokinase preparations on the course and prognosis of acute myocardial infarction].
    Pavlov AV; Iankin VV; Chausovskiĭ GM; Bokarev IN
    Klin Med (Mosk); 1991 Nov; 69(11):35-8. PubMed ID: 1839691
    [No Abstract]   [Full Text] [Related]  

  • 37. [Ischemic myocardial disease].
    Svennevig JL
    Nord Med; 1991; 106(1):2. PubMed ID: 1996228
    [No Abstract]   [Full Text] [Related]  

  • 38. [Evaluation of plasmin and trypsin by means of fibrinolytic and fibrinogenolytic methods].
    CURT BOECKEL CR
    Sem Med; 1961 Oct; 119():1315-7. PubMed ID: 13882747
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombolytic therapy for deep vein thrombosis: potential application of plasmin.
    Marder VJ
    Thromb Res; 2009; 123 Suppl 4():S56-61. PubMed ID: 19303506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.